[go: up one dir, main page]

AU2001263408A1 - C1 bacteriophage lytic system - Google Patents

C1 bacteriophage lytic system

Info

Publication number
AU2001263408A1
AU2001263408A1 AU2001263408A AU6340801A AU2001263408A1 AU 2001263408 A1 AU2001263408 A1 AU 2001263408A1 AU 2001263408 A AU2001263408 A AU 2001263408A AU 6340801 A AU6340801 A AU 6340801A AU 2001263408 A1 AU2001263408 A1 AU 2001263408A1
Authority
AU
Australia
Prior art keywords
bacteriophage lytic
lytic system
bacteriophage
lytic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263408A
Inventor
Vincent A. Fischetti
Daniel C. Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Original Assignee
Rockefeller University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University filed Critical Rockefeller University
Publication of AU2001263408A1 publication Critical patent/AU2001263408A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2001263408A 2000-05-23 2001-05-23 C1 bacteriophage lytic system Abandoned AU2001263408A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20653000P 2000-05-23 2000-05-23
US60206530 2000-05-23
PCT/US2001/016824 WO2001090331A2 (en) 2000-05-23 2001-05-23 C1 bacteriophage lytic system

Publications (1)

Publication Number Publication Date
AU2001263408A1 true AU2001263408A1 (en) 2001-12-03

Family

ID=22766801

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263408A Abandoned AU2001263408A1 (en) 2000-05-23 2001-05-23 C1 bacteriophage lytic system

Country Status (3)

Country Link
US (1) US6608187B2 (en)
AU (1) AU2001263408A1 (en)
WO (1) WO2001090331A2 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060234246A1 (en) * 1999-02-02 2006-10-19 Chiron Corporation Gene products differentially expressed in cancerous cells
US20030148268A1 (en) * 2001-12-06 2003-08-07 The Rockefeller University Novel method to identify targets for antibiotic development
DE10208877B4 (en) * 2002-03-01 2009-04-09 Erdmann, Volker A., Prof.Dr. Use of a streptavidin-binding peptide
ATE450544T1 (en) * 2002-03-01 2009-12-15 Volker A Erdmann STREPTAVIDIN BINDING PEPTIDE
WO2004020451A1 (en) * 2002-08-29 2004-03-11 The Uab Research Foundation Group b streptococcal phage lysin
CA2504331A1 (en) * 2002-11-14 2004-06-03 Gangagen, Inc. Bacteriophage having modified holin and uses thereof
WO2004052274A2 (en) 2002-12-09 2004-06-24 Phage Biopharm Llc Production of bacteriophage compositions for use in phage therapy
US7582729B2 (en) * 2003-05-15 2009-09-01 The Rockefeller University Nucleic acids and polypeptides of C1 bacteriophage and uses thereof
US20090215711A1 (en) * 2004-04-30 2009-08-27 Sagres Discovery, Inc. Novel compositions and methods in cancer
US20050282155A1 (en) * 2004-06-17 2005-12-22 Lucigen Corporation Viral libraries from uncultivated viruses and polypeptides produced therefrom
EP1618886A1 (en) * 2004-07-20 2006-01-25 Fonds zur Förderung der Forschung auf dem Gebiet der molekularen Virologie und Gentherapie Bacteriophage and prophage proteins in cancer gene therapy
US20060260606A1 (en) * 2005-05-18 2006-11-23 Coifman Robert E Inhalable formulations of amphotericin B and methods and devices for delivery thereof
US8394446B2 (en) 2005-07-25 2013-03-12 Abbott Cardiovascular Systems Inc. Methods of providing antioxidants to implantable medical devices
US7785647B2 (en) * 2005-07-25 2010-08-31 Advanced Cardiovascular Systems, Inc. Methods of providing antioxidants to a drug containing product
JP5292278B2 (en) * 2006-04-04 2013-09-18 サントル ナショナル ドゥ ラ ルシェルシュ スィヤンティフィック（セーエヌエルエス） Method for producing bacteriophage composition and method in the field of phage therapy
US20090092555A1 (en) * 2007-07-03 2009-04-09 Fischetti Vincent A Octameric Protein For Use In Bionanotechnology Applications
US9545431B1 (en) * 2008-05-23 2017-01-17 The United States Of America, As Represented By The Secretary Of Agriculture Isolated recombinant cDNA
US20090319031A1 (en) * 2008-06-19 2009-12-24 Yunbing Wang Bioabsorbable Polymeric Stent With Improved Structural And Molecular Weight Integrity
US8663580B2 (en) * 2010-11-01 2014-03-04 Agilent Technologies, Inc. Dried biological fluid spot punch device and related methods
US9005543B2 (en) * 2010-11-01 2015-04-14 Agilent Technologies, Inc. Apparatus for punching and solid phase extraction of dried biological fluid spot and related methods
DK2739975T3 (en) 2011-08-03 2015-08-17 Quidel Corp N-acetyl-D-glucosamine to INCREASED SPECIFICITY OF STREP-A-immunoassay.
JP2016523588A (en) 2013-05-06 2016-08-12 アボット カーディオヴァスキュラー システムズ インコーポレイテッド Hollow stent filled with therapeutic compound formulation
DE102013106455A1 (en) 2013-06-20 2014-12-24 Airbus Defence and Space GmbH Method for decontamination of bacteriological contaminants
GB201712733D0 (en) 2017-08-08 2017-09-20 Snipr Tech Ltd Methods & cells
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
WO2020077286A1 (en) * 2018-10-12 2020-04-16 Quidel Corporation Extraction reagent for use in an assay for detection of group a streptococcus
GB201901099D0 (en) 2019-01-27 2019-03-13 Snipr Biome Aps Methods, uses and compositions
JP2025525414A (en) 2022-06-29 2025-08-05 エスエヌアイピーアール・バイオーム・アーペーエス Targeting E. coli cells
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
FR3149206A1 (en) * 2023-06-02 2024-12-06 L'oreal Aqueous cosmetic composition comprising an endolysin and trehalose

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285649A4 (en) * 1986-10-08 1990-06-27 David Bernstein Method for exposing group a streptococcal antigens and an improved diagnostic test for the identification of group a streptococci.
US4957686A (en) 1990-02-06 1990-09-18 Norris Alan H Use of bacteriophages to inhibit dental caries
CA2186962A1 (en) 1994-04-05 1995-10-12 Richard M. Carlton Antibacterial therapy with genotypically modified bacteriophage
WO1995031562A1 (en) * 1994-05-12 1995-11-23 Quest International B.V. Process for inhibiting the growth of a culture of lactic acid bacteria, and optionally lysing the bacterial cells, and uses of the resulting lysed culture
US6056954A (en) 1997-10-31 2000-05-02 New Horizons Diagnostics Corp Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses
US5997862A (en) * 1997-10-31 1999-12-07 New Horizons Diagnostics Corporation Therapeutic treatment of group A streptococcal infections
MXPA01008701A (en) 1999-02-25 2003-06-24 New Horizons Diagnostics Inc A means for the prophylactic and therapeutic treatment of streptococcal infections.

Also Published As

Publication number Publication date
WO2001090331A3 (en) 2002-06-06
US6608187B2 (en) 2003-08-19
US20020058027A1 (en) 2002-05-16
WO2001090331A2 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
AU2001263408A1 (en) C1 bacteriophage lytic system
AU2001239746A1 (en) Group-browsing system
AU2001284246A1 (en) Electrosurgery system
AUPQ802400A0 (en) Propulsion system
AU2002215952A1 (en) Security system
AU7001701A (en) Liveexception system
AU2001292055A1 (en) Colour system
AU2002212516A1 (en) Suspension system
AU2001259186A1 (en) Ticketless admission system
AU2001285740A1 (en) New catalyst system
GB2366895B (en) Ticketless system
AU2002224845A1 (en) Viral expression system
AU2001289885A8 (en) Air-preparation system
AU2002227019A1 (en) Cashcalling and voicemining system
AU2001234177A1 (en) Answer-phone message providing system
GB2383228B (en) Distributed discovery system
GB0030060D0 (en) Propulsion system
GB0112389D0 (en) Locking system
AU2001293667A1 (en) Buckle-fastener system
AU2002222967A1 (en) Security system
AU3763001A (en) Security system
AU2001278704A1 (en) Receiving system
AU6366001A (en) Propulsion system
IL137053A0 (en) Locking system
AU2001288201A1 (en) Emergency system